BamSEC and AlphaSense Join Forces
Learn More

FibroBiologics Inc. – Material Contracts

NASDAQ: FBLG    
Share price (8/5/26): $0.87    
Market cap (8/5/26): $5.779 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.7
from 10-Q 3 pages Sublease Buyout Agreement
12/34/56
EX-10.2
from 8-K 30 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 45 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 8 pages Fibrobiologics, Inc. Stock Option Agreement Under the 2026 Equity and Incentive Compensation Plan
12/34/56
EX-10.1
from 8-K 22 pages Fibrobiologics, Inc. 2026 Equity and Incentive Compensation Plan 1. Purpose. the Purpose of This Plan Is to Permit Award Grants to Participants and to Provide to Such Persons Incentives and Rewards for Service and/or Performance. 2. Definitions. in Addition to Other Terms Defined Elsewhere in This Plan, as Used in This Plan: A. “Appreciation Right” Means a Right Granted Pursuant to Section 5 of This Plan. B
12/34/56
EX-10.1
from 8-K 40 pages Securities Purchase Agreement
12/34/56
EX-10.26
from S-1 37 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 3 pages Material contract
12/34/56
EX-10.1
from 8-K 34 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 33 pages Securities Purchase Agreement
12/34/56
EX-10.3
from 8-K 19 pages Form of Pre-Funded Common Stock Purchase Warrant Fibrobiologics, Inc
12/34/56
EX-10.2
from 8-K 22 pages Form of Common Stock Purchase Warrant Fibrobiologics, Inc
12/34/56
EX-10.1
from 8-K 32 pages Securities Purchase Agreement
12/34/56
EX-10.3
from 10-Q 15 pages Fibrobiologics, Inc. Consulting Agreement
12/34/56
EX-10.1
from 10-Q 12 pages Fibrobiologics, Inc. Employment Agreement
12/34/56
EX-10.1
from 8-K 21 pages Fibrobiologics, Inc. Convertible Promissory Note
12/34/56
EX-10.1
from 8-K 11 pages Fibrobiologics, Inc. Employment Agreement
12/34/56
EX-10.1
from 8-K 21 pages Fibrobiologics, Inc. Convertible Promissory Note
12/34/56
EX-10.15
from S-1 2 pages October 29, 2024 ● Health Insurance, Short-Term Disability, Long-Term Disability, and Life Insurance. These Benefits Are Provided Through Our Professional Employment Organization, Insperity, and an Overview of These Benefits Are Included With This Offer Letter
12/34/56
EX-10.14
from S-1 14 pages October 28, 2024 Mr. Mark Andersen Chief Financial Officer Fibrobiologics, Inc. 455 E. Medical Center Blvd., Suite 300 Houston, Texas 77598 Re: Transition
12/34/56